ZIMV ZimVie Inc.

Nasdaq zimvie.com


$ 18.99 $ 0.00 (0 %)    

Thursday, 16-Oct-2025 16:11:30 EDT
QQQ $ 593.40 $ 0.00 (0 %)
DIA $ 456.36 $ 0.00 (0 %)
SPY $ 654.59 $ 0.00 (0 %)
TLT $ 91.46 $ 0.00 (0 %)
GLD $ 399.71 $ 0.00 (0 %)
$ 18.99
$ 18.98
$ 18.83 x 17
$ 19.02 x 997
-- - --
$ 8.15 - $ 19.01
219,905
na
535.54M
$ 1.14
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-30-2025 06-30-2025 10-Q
2 05-08-2025 03-31-2025 10-Q
3 02-26-2025 12-31-2024 10-K
4 10-30-2024 09-30-2024 10-Q
5 08-01-2024 06-30-2024 10-Q
6 05-08-2024 03-31-2024 10-Q
7 02-28-2024 12-31-2023 10-K
8 11-01-2023 09-30-2023 10-Q
9 08-02-2023 06-30-2023 10-Q
10 05-03-2023 03-31-2023 10-Q
11 03-01-2023 12-31-2022 10-K
12 11-09-2022 09-30-2022 10-Q
13 08-10-2022 06-30-2022 10-Q
14 05-05-2022 03-31-2022 10-Q
15 03-31-2022 12-31-2021 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 zimvie-stockholders-approve-acquisition-by-archimed-affiliate-merger-expected-to-close-on-october-20

ZimVie Inc. ("ZimVie") (NASDAQ:ZIMV) today announced that at the special meeting of ZimVie stockholders held on October...

 zimvie-announces-a-strategic-distribution-agreement-with-osstem-implant-co-to-further-expand-its-presence-into-the-large-growing-chinese-implant-market

PALM BEACH GARDENS, Fla., July 23, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the den...

 barclays-upgrades-zimvie-to-equal-weight-raises-price-target-to-19

Barclays analyst Matt Miksic upgrades ZimVie (NASDAQ:ZIMV) from Underweight to Equal-Weight and raises the price target from...

 archimed-affiliate-to-acquire-zimvie-for-730m-offering-99-premium-over-90-day-vwap

ZimVie Inc. ("ZimVie") (NASDAQ:ZIMV), a global life sciences leader in the dental implant market, today announced their...

 zimvie-launches-realguide-software-suite-and-implant-concierge-service-in-japan

ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental implant market, today announced the launch of its RealGU...

 ubs-maintains-neutral-on-zimvie-lowers-price-target-to-10

UBS analyst Kevin Caliendo maintains ZimVie (NASDAQ:ZIMV) with a Neutral and lowers the price target from $16 to $10.

 zimvie-affirms-fy2025-adj-eps-guidance-of-080-095-vs-084-est-affirms-fy2025-sales-guidance-of-44500m-46000m-vs-45035m-est

ZimVie (NASDAQ:ZIMV) affirms FY2025 Adj EPS guidance from $0.80-$0.95 to $0.80-$0.95 vs $0.84 analyst estimate. Affirms FY2025 ...

 zimvie-q1-adj-eps-027-beats-021-estimate-sales-11200m-miss-11341m-estimate

ZimVie (NASDAQ:ZIMV) reported quarterly earnings of $0.27 per share which beat the analyst consensus estimate of $0.21 by 28.57...

 needham-reiterates-hold-on-zimvieto-hold

Needham analyst David Saxon reiterates ZimVie (NASDAQ:ZIMV) from Hold to Hold.

 dental-players-dentsply-sirona-zimvie-show-weak-growth-outlook-analyst

Needham downgraded Dentsply Sirona and ZimVie, citing weak growth, market share losses, and demand challenges amid high interes...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION